In this presentation, we explore the rapid growth of the CAR T market, driven by oncology advancements and innovative clinical applications. Key challenges in CAR T manufacturing, such as supply capacity and manual processes, are addressed through Lanza's Cocoon platform. This automated solution consolidates manufacturing steps, reduces vein-to-vein time, and enhances product quality. The presentation highlights the platform's components, the rapid manufacturing process, and its effectiveness in producing robust CAR T cells. Watch the video to learn more.
Speaker: Tamara Laskowski, PhD, Senior Director, Clinical Development